Ontogeny of the humoral immune response to human immunodeficiency virus type 1 in infants.

D Henrard, M Fauvel, J Samson, G Delage, M Boucher, C Hankins, J Stephens, N Lapointe
Author Information
  1. D Henrard: Abbott Laboratories, Abbott Park, IL 60064.

Abstract

In a cohort of infants born to human immunodeficiency virus type 1 (HIV-1)-infected mothers, changes in the levels of HIV-1 specific antibodies were measured during the first year of life. In uninfected children, the level of antibodies to six HIV-1 antigens (gp120, p66, p41, p31, p24, and p17) decreased continuously until becoming negative. In contrast, rising levels of one or more specific antibodies were detected in 9 of 12 infected children at a median age of 6 months. At 1 year of age, 8 infants were still asymptomatic and classified as P-1. All had serologic profiles consistent with de novo specific antibody production. In contrast, among the 4 infants who had early disease (class P-2), 3 had no significant rise in antibody to HIV-1. These results indicate that poor immune response, which could result from early infection of the infant, is often associated with rapid clinical progression.

MeSH Term

Cohort Studies
HIV Antibodies
HIV Antigens
HIV Infections
HIV-1
Humans
Infant
Infant, Newborn
Polymerase Chain Reaction

Chemicals

HIV Antibodies
HIV Antigens